The FDA published a warning letter it sent to Aros Surgical Instruments requesting the firm cease sales of its surgical sutures and micro anastomosis clamps.
The letter was sent based upon issues the agency found during a February inspection of the company’s Newport Beach, Calif. location.
The federal watchdog reported that the company had responded later in February to its initial concerns, and the FDA produced the warning letter in response.
Help employers find you! Check out all the jobs and post your resume.
